SCHEMBL30258631

SCHEMBL30258631

CC(C#N)c1nn(C)c2cc(Br)ccc12

nearest known ligand 0.35

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
▸ PDGFRA P16234 1/20 0.35
▸ CDK5 Q00535 1/20 0.35
▸ TYRO3 Q06418 1/20 0.35
▸ ADORA2A P29274 1/20 0.32
▸ ADORA2B P29275 1/20 0.32
▸ HDAC8 Q9BY41 2/20 0.31
▸ MAPK8 P45983 1/20 0.31
▸ BACE1 P56817 1/20 0.31
▸ CHEK1 O14757 1/20 0.31
▸ SMN1; SMN2 Q16637 2/20 0.31
▸ LMNA P02545 1/20 0.31
▸ HTT P42858 1/20 0.31
▸ ESR1 P03372 1/20 0.31
▸ PDE10A Q9Y233 1/20 0.30
▸ HTR2A P28223 1/20 0.30
▸ HTR2C P28335 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26621523 1.00 PDGFRA (0.35) PDGFRACDK5TYRO3ADORA2AADORA2B
SCHEMBL26289032 0.83 PDGFRA (0.39) PDGFRACDK5TYRO3ADORA2AADORA2B
SCHEMBL20520407 0.80 PDGFRA (0.40) PDGFRACDK5TYRO3ADORA2AADORA2B
SCHEMBL30645727 0.80 PDGFRA (0.40) PDGFRACDK5TYRO3ADORA2AADORA2B
SCHEMBL17802138 0.75 PDGFRA (0.38) PDGFRACDK5TYRO3ADORA2AADORA2B
SCHEMBL29985546 0.75 PDGFRA (0.38) PDGFRACDK5TYRO3ADORA2AADORA2B
SCHEMBL26621602 0.72 CSNK2A1 (0.40) PDGFRACDK5TYRO3ADORA2AADORA2B
SCHEMBL30258316 0.72 CSNK2A1 (0.40) PDGFRACDK5TYRO3ADORA2AADORA2B
SCHEMBL30032217 0.71 ADORA2A (0.59) PDGFRACDK5TYRO3ADORA2AADORA2B
SCHEMBL2144982 0.71 ADORA2A (0.59) PDGFRACDK5TYRO3ADORA2AADORA2B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4735438-A2 HETEROBIFUNCTIONAL COMPOUNDS FOR THE DEGRADATION OF KRAS Merck Patent GmbH (DE) 2026-05-06 — — EP disclosed
EP-4735452-A2 HETEROBIFUNCTIONAL COMPOUNDS FOR THE DEGRADATION OF KRAS PROTEIN Merck Patent GmbH (DE) 2026-05-06 — — EP disclosed
CN-119604493-A Heterocyclic compounds as BCL6 modulators useful as ligand-directed degradants 细胞基因公司 2025-03-11 — — CN disclosed
WO-2025006783-A2 HETEROBIFUNCTIONAL COMPOUNDS FOR THE DEGRADATION OF KRAS MERCK PATENT GMBH (DE) 2025-01-02 — — WO disclosed
WO-2025006753-A2 HETEROBIFUNCTIONAL COMPOUNDS FOR THE DEGRADATION OF KRAS PROTEIN MERCK PATENT GMBH (DE) 2025-01-02 — — WO disclosed
WO-2023059792-A1 CORONAVIRUS NON-STRUCTURAL PROTEIN 3 DEGRADING COMPOUNDS C4 THRAPEUTICS, INC. (US) 2023-04-13 — — WO disclosed
Send feedback